Pall Expands Operations in PR

Pall Corp has plans to expand its Life Sciences manufacturing operations in Fajardo, PR in order to meet increasing demand by pharmaceutical and biotechnology companies, blood centers and hospitals. The company expects to invest approximately $50 million in facilities, machinery and equipment and add more than 250 full-time jobs in PR by 2010.

The expansion in PR is part of the company’s standardization and consolidation efforts with respects to its global manufacturing business. The company anticipates that PR’s competitive tax rate combined with its facilities optimization program will result in an incremental after tax benefit of more than $10 million annually in three years.

Eric Krasnoff, chairman and chief executive officer of Pall, stated, “Puerto Rico’s attractive business climate and strong commitment to developing biopharmaceutical manufacturing capability are key factors in bringing numerous drug and biotechnology companies to the island. Expanding our operations in Puerto Rico is an important part of our strategic approach of aligning with customers worldwide and increasing production in lower tax rate jurisdictions.”